СИСТЕМНОЕ ВОСПАЛЕНИЕ ПРИ АТЕРОСКЛЕРОЗЕ НА ФОНЕ ХРОНИЧЕСКОГО ПАРОДОНТИТА
Ключевые слова:
parodontit, yurak ishеmik kasalligi, miokard infarkti, ateroskleroz, C-reaktiv oqsil, кolxitsin.Аннотация
Современные данные показывают, что при наиболее эффективном лечении атеросклероза и всех заболеваний сердечно-сосудистой системы необходимо следовать 3 основным принципам указанного заболевания. Это: контроль дислипидемии, контроль гемостаза и контроль воспалительной реакции[29]. В последние годы возросло внимание к колхицину как противовоспалительному средству не только при лечении подагры, но и при лечении больных инфарктом миокарда и хроническими сердечно-сосудистыми заболеваниями[30]. Противовоспалительное действие колхицина связано с несколькими механизмами, основным из которых является уменьшение и ликвидация воспалительного процесса. С целью повышения эффективности лечения при заболеваниях суставов и атеросклерозе введение колхицина снижает и устраняет факторы риска, способные вызвать заболевания.
Библиографические ссылки
Borgnakke WS, Ylöstalo PV, Taylor GW, et al. Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence. J Clin Periodon-l 2013;40 Suppl 14:S135–52.
Chandan JS, Thomas T, Bradbury-Jones C, et al. Intimate partner violence and temporomandibular joint disorder. J Dent 2019;82:98–100.
Asikainen S, Jousimies-Somer H, Kanervo A, Saxén L. Actinobacillus actinomycetemcomitans and clinical periodontal status in Finnish juvenile periodontitis patients. J Periodontol 1986;57:91-
Chandan JS, Thomas T, Bradbury-Jones C, et al. Female survivors of intimate partner violence and risk of depression, anxiety and serious mental illness. Br J Psychiatry 2020;217:562–
Badimon L, Peña E, Arderiu G, et al. C-Reactive protein in atherothrombosis and angiogenesis. Front Immunol 2018;9:9430–430.
Blak BT, Thompson M, Dattani H, et al. Generalisability of the health improvement network (thin) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care 2011;19:251–5.
NHS Digital. Quality and Outcomes Framework (QOF) business rules v42 2019-2020 baseline release - NHS Digital, 2019. Available: https://digital.nhs.uk/data-and-information/data-collections-and- data-sets/data-collections/quality-and-outcomes-framework-qof/ quality-and-outcome-framework-qof-business-rules/quality-and- outcomes-framework-qof-business-rules-v42-2019-2020-baseline- releas [Accessed 31 Jul 2019].
Chandan JS, Keerthy D, Zemedikun DT, et al. The association between exposure - childhood maltreatment and the subsequent development of functional somatic and visceral pain syndromes. EClinicalMedicine 2020;23:100392.
Roca-Millan E, González-Navarro B, Sabater-Recolons M-M, et al. Periodontal treatment on patients with cardiovascular disease: systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal 2018;23:e681–90.
Nutalapati R, Kasagani SK, Jampani ND, Mutthineni RB, Chintala S, Kode VS. Comparative evaluation of amoxicillin plus metronidazole and doxycycline alone in the nonsurgical treatment of localized aggressive periodontitis. Indian J Oral Sci 2014;5:112-8.
Teeuw WJ, Slot DE, Susanto H, et al. Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta- analysis. J Clin Periodontol 2014;41:70–9.
Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363–9.
Lin C-Y, Tseng C-F, Liu J-M, et al. Association between periodontal disease and subsequent sjögren’s syndrome: A nationwide population-based cohort study. Int J Environ Res Public Health 2019;16:771.
Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017;377:1119–31.
Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline. J Clin Periodontol 2020;47 Suppl 22:4–60.
Lafon A, Pereira B, Dufour T, et al. Periodontal disease and stroke: a meta-analysis of cohort studies. Eur J Neurol 2014;21:1155–67.
Orlandi M, Graziani F, D'Aiuto F. Periodontal therapy and cardiovascular risk. Periodontol 2000 2020;83:107–24.
Seitz MW, Listl S, Bar-ls A, et al. Current knowledge on correlations between highly prevalent dental conditions and chronic diseases: an umbrella review. Prev Chronic Dis 2019;16:180641.
Chandan JS, Thomas T, Gokhale KM, et al. The burden of mental ill health associated with childhood maltreatment in the UK, using the health improvement network database: a population-based retrospective cohort study. Lancet Psychiatry 2019;6:926–34.
Fiolet ATL, Silvis MJM, Opstal TSJ, et al. Short-Term effect of low- dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high- sensitivity C-reactive protein. PLoS One 2020;15:e0237665.
Agababyan I.R., Soleeva S.Sh. The place of statins in the complex treatment of SARS-CoV-2. Issues of science and education.. 2021. №14 (139). с.70-80. (in Russ).
Leung Y.Y., Hui L.L., Kraus W.B. Colchicine - update on mechanisms of action and therapeutic applications. Semin Arthritis Rheum 2015; 45: 341-50. (in Russ).
Dalbet N, Lauterio TJ, Wolfe HR. The mechanism of action of colchicine in the treatment of gout. Clin Ther 2014; 36: 1465-79. (in Russ).
Tardif JC, Kuz S, Waters DJ, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 2019; 381: 2497-505.(in Russ).
Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Colchicine in low doses for secondary prevention of cardiovascular diseases. J Am Coll Cardiol 2013; 61: 404-10. (in Russ).
Hemkens LG, Ewald H, Gloy WL, et al. Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis. Heart 2016; 102: 590-6. (in Russ).
28.Araújo MM, Martins CC, Costa LCM, et al. Association between depression and periodontitis: a systematic review and meta-analysis. J Clin Periodon-l 2016;43:216–28.2022). ОЕ ВОСПАЛЕНИЕ КРИЧИННО-СЛЕДСТВ
Rizaev E. A., Agababyan I. R., Arzikulova M. Sh. K. AUTOIMMUNE INFLAMMATION AS A CAUSE-AND-EFFECT RELATIONSHIP OF PERIODONTITIS AND ATHEROSCLEROSIS // Issues of science and education. – 2022. – №. 6 (162). – С. 50-64.(in Russ).
Aghababyan I.R., Ismailov R.M. – RELATIONSHIP OF THE LEVEL OF NEUTROPHILS IN PERIODONTITIS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASES46 NEW DAY MEDICINE-2 (52) 2023.
Alimjanovich, R. J., Sattor o’g’li, N. O., & Mahmayusuf o’g’li, I. R. (2023). DEPENDENCE OF NEUTROPHIL LEVEL ON PERIODONTAL CONDITION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE. (LITERARY REVIEW).JOURNAL OF BIOMEDICINE AND PRACTICE, 8(1). (in Russ).
Rizaev , Zh. A., Aghababyan , I. R., Yarasheva , Z. Kh., & Mukhamedova , M. G. (2022). The importance of comorbid conditions in the development of chronic heart failure in elderly and senile patients. Achievements of science and education, (1 (81)), 75-79.
JA Rizaev , I. R. Agababyan , YAIsmoilova ACTIVITIES OF CLINICS
